NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,082,000 | +88.2% | 9,716 | +0.1% | 0.02% | +66.7% |
| Q2 2020 | $575,000 | -8.0% | 9,706 | +4.7% | 0.01% | -25.0% |
| Q1 2020 | $625,000 | -14.5% | 9,274 | +7.0% | 0.02% | 0.0% |
| Q4 2019 | $731,000 | -29.8% | 8,669 | -37.7% | 0.02% | -38.5% |
| Q3 2019 | $1,041,000 | -39.7% | 13,925 | -49.0% | 0.03% | -43.5% |
| Q2 2019 | $1,725,000 | +68.0% | 27,287 | +27.9% | 0.05% | +58.6% |
| Q1 2019 | $1,027,000 | +67.0% | 21,330 | +16.1% | 0.03% | +45.0% |
| Q4 2018 | $615,000 | -29.1% | 18,365 | +11.0% | 0.02% | -20.0% |
| Q3 2018 | $867,000 | +294.1% | 16,540 | +135.3% | 0.02% | +257.1% |
| Q2 2018 | $220,000 | – | 7,028 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |